MedPath

Intestinal Microbiota Adaptation to Prebiotic Administration

Not Applicable
Completed
Conditions
Healthy
Interventions
Dietary Supplement: Prebiotic
Registration Number
NCT04164914
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Brief Summary

Non-absorbable, fermentable residues in the diet increase intestinal gas production and induce gas-related symptoms, such as flatulence, abdominal bloating and distention; however, prebiotics, which are also fermented by colonic bacteria, have been shown to improve this type of symptoms. The aim is to demonstrate whether a prebiotic induces adaptive changes in metabolic activity of gut microbiota and colonic biomass that explain its beneficial effect on gas-related symptoms.

Single-centre, single arm, open label, proof-of-concept study in healthy subjects. The study will consist of a pre-administration phase (2 wk), an administration phase (4 wk) and a post-administration phase (2 wk). A soluble prebiotic fiber (resistant dextrin 14 g/d) will be administered during the 4 wk administration phase. During 4 days immediately before, at the beginning and at the end of the administration phase and at the end of the post-administration phase participants will be put on a standard diet and the following outcomes will be measured: a) number of gas evacuations during daytime for 2 days by means of an event marker; b) volume of gas evacuated via a rectal tube during 4 hours after a test meal, by means of a barostat; c) microbiota composition by fecal analysis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
Exclusion Criteria
  • gastrointestinal symptoms
  • recent (3 months) antibiotic intake
  • change in dietary habits 4 weeks before

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Healthy subjectsPrebioticPrebiotic administration
Primary Outcome Measures
NameTimeMethod
Number of daily anal gas evacuations28 days

Change in the number of anal gas evacuations measured by an event marker from beginning of treatment to end of treatment

Secondary Outcome Measures
NameTimeMethod
Volume of anal gas evacuation28 days

Change in the volume of anal gas evacuated for 4 hours after a probe meal from beginning of treatment to end of treatment

Microbiota composition by fecal analysis28 days

Change from beginning of treatment to end of treatment

Trial Locations

Locations (1)

Vall d'Hebron Research Institut

🇪🇸

Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath